Equipment and Processing Report-09-20-2017

With most biologics in development taking injectable form, drug makers are increasingly exploring the use of prefillable syringe and self-injection systems for their administration; the adoption of QbD principles helps to ensure that components are engineered with stringent and specialized needs in mind.

Support from FDA, a best practice guide, collaborative research, and new facilities signify progress in solid-dosage continuous manufacturing.